Clinical Trials Browser

Phase 1/2 × Unknown × Dasatinib × Clear all

NCT05559008 2022-11-09

A Umbrella Study in R/R PTCL Guided by Molecular Subtypes

Phase 1/2 Unknown

Lymphoma, T-Cell, Peripheral